These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13480003)

  • 21. [Dual effect of lysergic acid diethylamide on uterine contractions induced by 5-hydroxytryptamine (serotonin)].
    DELAY J; THUILLIER J
    C R Seances Soc Biol Fil; 1956; 150(7):1335-6. PubMed ID: 13397064
    [No Abstract]   [Full Text] [Related]  

  • 22. [Some observations on the action of massive doses of 5-hydroxytryptamine on the central nervous system].
    MANTEGAZZINI P
    Boll Soc Ital Biol Sper; 1956; 32(7-8):839-41. PubMed ID: 13404167
    [No Abstract]   [Full Text] [Related]  

  • 23. [Teratogenic action of LSD-25 on the central nervous system in mouse fetuses].
    Araszkiewicz H; Bartel H
    Folia Morphol (Warsz); 1972; 31(4):565-74. PubMed ID: 4539123
    [No Abstract]   [Full Text] [Related]  

  • 24. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative edematigenous action in vitro of 5-hydroxytryptamine & histamine on central nervous tissue].
    GOMIRATO G; ZANALDA A
    Arch Sci Med (Torino); 1958 Sep; 106(3):323-5. PubMed ID: 13584109
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of LSD 25, BOL 148, bufotenine, mescaline and ibogaine on the potentiation of hexobarbital hypnosis produced by serotonin and reserpine.
    SALMOIRAGHI GC; PAGE IH
    J Pharmacol Exp Ther; 1957 May; 120(1):20-5. PubMed ID: 13449697
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of LSD on the central nervous system (review)].
    Popova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):457-62. PubMed ID: 4978646
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on spinal reflex].
    WEIDMANN H
    Helv Physiol Pharmacol Acta; 1957; 15(2):C 43-4. PubMed ID: 13474596
    [No Abstract]   [Full Text] [Related]  

  • 29. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD; Breeding M; Sanders-Bush E
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of LSD-serotonin central interaction.
    ZANOWIAK P; RODMAN MJ
    J Am Pharm Assoc Am Pharm Assoc; 1959 Mar; 48(3):165-8. PubMed ID: 13641044
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of serotonin and lysergic acid diethylamide in the Siamese fighting fish.
    TROUT DL
    J Pharmacol Exp Ther; 1957 Sep; 121(1):130-5. PubMed ID: 13481835
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of serotonin inhibitors and derivatives of phenylethylamine on serotonin-induced psychomotor depression in mice].
    Fischer E; Saavedra JM; Smolovich J
    C R Seances Soc Biol Fil; 1968; 162(8):1623-4. PubMed ID: 4238204
    [No Abstract]   [Full Text] [Related]  

  • 34. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antagonism between LSD and 5-HT on the motor initiative of the fish (Carassius auratus)].
    SACCHI U; GIANNIOTTI G
    Boll Soc Ital Biol Sper; 1956; 32(3-5):177-9. PubMed ID: 13342212
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

  • 38. The inhibition of human brain acetylcholinesterase by LSD-25 and JB-336 in vitro.
    Bajgar J; Patocka J; Zizkovský V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1971; 14(4):417-23. PubMed ID: 5291385
    [No Abstract]   [Full Text] [Related]  

  • 39. The site of action of D-lysergic acid diethylamide and 5-hydroxytryptamine in the melanophore test.
    BERDE B; CERLETTI A
    Z Gesamte Exp Med; 1957; 129(2):149-53. PubMed ID: 13531236
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.